aTyr Pharma Inc.
(ATYR)
undefined
undefined%
At close: undefined
4.00
1.39%
After-hours Jan 06, 2025, 07:41 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -50.39M | -45.34M | -33.77M | -16.22M | -23.60M | -34.52M | -48.21M | -57.85M | -47.97M | -24.35M | -20.01M | -17.61M |
| Depreciation & Amortization | 2.74M | 1.70M | 1.30M | 1.27M | 1.37M | 746.00K | 713.00K | 900.00K | 869.00K | 829.00K | 714.00K | 540.00K |
| Stock-Based Compensation | 2.60M | 2.15M | 1.61M | 1.47M | 1.78M | n/a | n/a | n/a | 4.86M | 1.79M | 155.00K | n/a |
| Other Working Capital | 2.70M | 4.35M | -4.24M | -2.08M | 44.00K | 610.00K | 761.00K | -1.35M | 3.28M | -1.25M | 1.85M | 37.00K |
| Other Non-Cash Items | -3.18M | 11.16M | 2.93M | 4.63M | 4.59M | 7.70M | 10.78M | 7.25M | 2.17M | 156.00K | -15.00K | 4.90M |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 15.01M | -833.00K | -2.59M | -2.26M | 206.00K | -1.45M | -1.73M | -1.35M | 3.28M | -1.25M | 1.85M | 787.00K |
| Operating Cash Flow | -33.22M | -41.89M | -33.08M | -15.30M | -20.01M | -31.06M | -42.36M | -52.86M | -36.80M | -22.82M | -17.31M | -11.38M |
| Capital Expenditures | -4.21M | -1.64M | -192.00K | -202.00K | -79.00K | -594.00K | -1.31M | -600.00K | -664.00K | -249.00K | -644.00K | -598.00K |
| Acquisitions | n/a | 179.00K | 50.00K | 18.00K | 51.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -106.98M | -42.12M | -126.51M | -21.07M | -40.65M | -40.30M | -77.67M | -28.09M | -109.44M | -5.40M | n/a | n/a |
| Sales Maturities Of Investments | 91.05M | 90.83M | 35.08M | 28.15M | 45.60M | 78.06M | 51.35M | 62.22M | 38.12M | 3.40M | n/a | n/a |
| Other Investing Acitivies | 15.00K | 48.89M | -91.37M | 7.10M | 5.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -20.13M | 47.24M | -91.57M | 6.90M | 4.92M | 37.17M | -27.64M | 33.53M | -71.99M | -2.25M | -644.00K | -598.00K |
| Debt Repayment | -394.00K | -66.00K | n/a | -9.08M | -8.00M | -4.67M | 9.87M | 4.53M | -5.24M | 3.44M | 12.00M | 1.65M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 105.00K | 45.00K | 73.00K | 10.00K | 13.00K | 50.00K | 361.00K | 163.00K | 75.65M | -927.00K | 38.74M | n/a |
| Financial Cash Flow | 66.23M | 5.45M | 110.03M | 16.14M | 1.34M | -4.24M | 52.70M | 4.70M | 147.92M | 2.51M | 50.74M | 1.66M |
| Net Cash Flow | 12.88M | 7.64M | -14.62M | 7.74M | -13.75M | 1.87M | -17.30M | -14.64M | 39.13M | -22.56M | 32.78M | n/a |
| Free Cash Flow | -37.44M | -43.53M | -33.27M | -15.50M | -20.09M | -31.66M | -43.68M | -53.46M | -37.46M | -23.07M | -17.95M | -11.98M |